Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yazmin Reategui-Almonacid
Observed names:
Yazmin Almonacid,
Yazmin Almonacid-reategui,
Yazmin Reategui,
Yazmin Reategui Almonacid,
Yazmin Reategui-almonacid
Institutions:
Rutgers, The State University of New Jersey,
Newark Beth Israel Medical Center,
Augusta University,
Rutgers Health
Observed institutions:
Rutgers, The State University of New Jersey,
Newark Beth Israel Medical Center,
Augusta University,
Rutgers Health
ORCID:
0009-0009-7923-577X
Observed ORCID:
0009-0009-7923-577X
OpenAlex ID:
A5099517404
IRF8: Mechanism of Action and Health Implications
2022
·
Hannah R. Moorman
, Yazmin Reategui
, et al.
·
Cells
·
69
PDF
Imatinib outcomes in chronic myeloid leukemia across diverse health care settings: a systematic review and meta-analysis
2026
·
Marisol Miranda-Galvis
, Joshua Wilson
, et al.
·
Blood Cancer Journal
·
5
PDF
Upfront endoscopic necrosectomy versus step-up endoscopic approach for walled-off pancreatic necrosis: a systematic review and meta-analysis
2026
·
Nkengeh Tazinkeng
, Fatima Elmustafa
, et al.
·
Gastrointestinal Endoscopy
·
2
Opioid-Induced Adrenal Insufficiency With Concurrent Opioid-Induced Esophageal Dysfunction Presenting With Achalasia-Like Features
2026
·
Albert Owusu-Ansah
, Vanessa Osei-Bonsu
, et al.
·
Annals of Internal Medicine Clinical Cases
·
1
Real-world data vs pivotal trial outcomes of imatinib in newly diagnosed chronic myeloid leukemia patients.
2025
·
Yazmin Reategui-Almonacid
, Marisol Miranda
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Unveiling oncologists' geographical journey: Analyzing hematology/oncology fellowship graduates' relocation patterns and their impact on regional disparities in cancer care.
2024
·
Raag Patel
, Amany R. Keruakous
, et al.
·
Journal of Clinical Oncology
·
1
HiDAC Consolidation Cycles May Impede Stem Cell Transplant Planning for High-Risk Acute Myeloid Leukemia Patients
2023
·
Michael Stokes
, Danielle Bradshaw
, et al.
·
Journal of Clinical Haematology
·
1
PDF
Pulmonary Kaposi Sarcoma Presenting With Flame-Shaped Computed Tomography Opacities in Advanced HIV
2026
·
Yazmin Reategui Almonacid
, Astrid Camila Astacio Urena
, et al.
·
Annals of Internal Medicine Clinical Cases
The early-onset paradox: Advanced-stage colon cancer at presentation across socioeconomic and health system factors.
2026
·
Yazmin Reategui-Almonacid
, Aqsa Zoey Sorathia
, et al.
·
JCO Oncology Practice
PDF
Malnutrition in haematological malignancies: A nationwide analysis of outcomes, resource utilisation, and disparities (NIS 2021-2022).
2026
·
Jude O. Ossai
, Oyinkansola Priscilla Taiwo
, et al.
·
JCO Oncology Practice
PDF
Early palliative care integration and survival outcomes in metastatic colorectal cancer: A propensity-matched analysis of a national real-world cohort.
2026
·
Nnamdi Joseph Omenuko
, McKenna Andrews
, et al.
·
JCO Oncology Practice
PDF
POSTER: ABCL-300: CRISPR-Cas9 Targeting of CXCR4 in WHIM Syndrome as a Strategy to Overcome Microenvironmental Resistance in B-Cell Malignancies
2026
·
Albert Owusu-Ansah
, Jude Ossai
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
ABCL-285: CXCR4 Expression as a Determinant of Inferior Outcomes Following CD19 CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A National Cancer Database Analysis
2026
·
Albert Owusu-Ansah
, Jude Ossai
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
ABCL-300: CRISPR-Cas9 Targeting of CXCR4 in WHIM Syndrome as a Strategy to Overcome Microenvironmental Resistance in B-Cell Malignancies
2026
·
Albert Owusu-Ansah
, Jude Ossai
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CLL-580: Impact of Type 2 Diabetes on Cardiovascular Toxicity, Infectious Complications, and Survival Among Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Propensity Score-Matched TriNetX Analysis
2026
·
Jude Ossai
, Chidiebube Ugwu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1659: Prophylactic Tocilizumab During Bispecific Antibody Step-Up Dosing in Relapsed/Refractory Multiple Myeloma: CRS Mitigation, Low-Dose Strategies, and Outpatient Feasibility
2026
·
Valerin Arno
, Aqsa Zoey Sorathia
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
AML-193: Impact of Time to Chemotherapy Initiation on Overall Survival in Acute Myeloid Leukemia: A National Cancer Database Analysis
2026
·
Yazmin Reategui Almonacid
, Daniel Moncada
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CLL-1309: Anticoagulation Safety and Thromboembolic Outcomes in Patients With Chronic Lymphocytic Leukemia and Atrial Fibrillation Receiving BTK Inhibitors: A Propensity-Matched TriNetX Analysis
2026
·
Jude Ossai
, Oladayo Oyebanji
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-285: CXCR4 Expression as a Determinant of Inferior Outcomes Following CD19 CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A National Cancer Database Analysis
2026
·
Albert Owusu-Ansah
, Jude Ossai
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
AML-087: Nationwide Trends in Acute Myeloid Leukemia Mortality Arising From Philadelphia Chromosome–Negative Myeloproliferative Neoplasms in the United States, 1999–2023
2026
·
Valerin Arno Encarnacion
, Aqsa Sorathia
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-193: Impact of Time to Chemotherapy Initiation on Overall Survival in Acute Myeloid Leukemia: A National Cancer Database Analysis
2026
·
Yazmin Reategui Almonacid
, Daniel Moncada
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-087: Nationwide Trends in Acute Myeloid Leukemia Mortality Arising From Philadelphia Chromosome–Negative Myeloproliferative Neoplasms in the United States, 1999–2023
2026
·
Valerin Arno Encarnacion
, Aqsa Sorathia
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CLL-1309: Anticoagulation Safety and Thromboembolic Outcomes in Patients With Chronic Lymphocytic Leukemia and Atrial Fibrillation Receiving BTK Inhibitors: A Propensity-Matched TriNetX Analysis
2026
·
Jude Ossai
, Oladayo Oyebanji
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MM-1659: Prophylactic Tocilizumab During Bispecific Antibody Step-Up Dosing in Relapsed/Refractory Multiple Myeloma: CRS Mitigation, Low-Dose Strategies, and Outpatient Feasibility
2026
·
Valerin Arno
, Aqsa Zoey Sorathia
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CLL-580: Impact of Type 2 Diabetes on Cardiovascular Toxicity, Infectious Complications, and Survival Among Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Propensity Score–Matched TriNetX Analysis
2026
·
Jude Ossai
, Chidiebube Ugwu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
38
Citation count:
80
H-index:
2
I10-index:
1
Year
Topic
Type